A Clinical Study to Test Long Term Safety of GLPG1690 for Patients With Systemic Sclerosis

Stopped early · Phase 2 · Has a placebo group

Conditions studied: Systemic Sclerosis

In brief

This study was the extension of the double-blind study GLPG1690-CL-204 (NCT03798366). The main purpose of the study was to see how GLPG1690 was tolerated in participants with systemic sclerosis and whether there were any side effects in a long-term treatment period.

Key facts

Study ID

NCT03976648

Run by

Lakefront Biotherapeutics NV

People needed

31

Starts

2019-07-18

Expected to finish

2021-04-13

Last updated by the study team

2022-03-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female participants who completed the 24-week treatment period of Study GLPG1690-CL-204 and who according to the investigator's judgment may benefit from long-term treatment with GLPG1690.

You may not qualify if…

• Any condition or circumstances that, in the opinion of the investigator, may make a participant unlikely or unable to complete the study or comply with study procedures and requirements.

Where it is running

• Pacific Arthritis Care Center — Los Angeles, California, United States
• UCLA Rheumatology — Los Angeles, California, United States
• RASF Clinical Research Center — Boca Raton, Florida, United States
• University of Michigan — Ann Arbor, Michigan, United States
• Metroplex Clinical Research Center — Dallas, Texas, United States
• UT Physicians Center for Autoimmunity — Houston, Texas, United States
• UZ Gent — Ghent, Belgium
• UZ Leuven — Leuven, Belgium
• Azienda Ospedaliero Universitaria Careggi — Florence, Italy
• Ospedale San Raffaele S.r.l. - PPDS — Milan, Italy
• Hospital Universitario Vall d'Hebron — Barcelona, Spain
• Hospital Universitario 12 de Octubre — Madrid, Spain
• University Hospital Aintree — Liverpool, United Kingdom
• Royal Free Hospital — London, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.